Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Talbot

Showing results (51-60 of 255) with videos related to

Pageof 26
Sort By:
Human Molecular Genetics|December 17, 2009
Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model miceBradley J Turner, Steven Ackerley, Kay E Davies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 12, 2015
Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosisMartin R Turner, Raph Goldacre, Kevin Talbot, et al.
Annals of Neurology|October 21, 2016
Psychiatric disorders prior to amyotrophic lateral sclerosisMartin R Turner, Raph Goldacre, Kevin Talbot, et al.
Brain Communications|August 14, 2023
Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosisAlexander G Thompson, Rachael Marsden, Kevin Talbot, et al.
Journal of Medical Ethics|July 11, 2013
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseasesLes Halpin, Julian Savulescu, Kevin Talbot, et al.
Brain : a Journal of Neurology|November 15, 2011
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosisGwenaëlle Douaud, Nicola Filippini, Steven Knight, et al.
Neuromuscular Disorders : NMD|September 18, 2012
Spinal muscular atrophy at the crossroads of basic science and therapyJames N Sleigh, Stuart J Grice, Kay E Davies, et al.
Neurobiology of Disease|April 1, 2009
Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse modelBradley J Turner, Nicholas J Parkinson, Kay E Davies, et al.
Molecular Neurobiology|February 21, 2018
Towards a TDP-43-Based Biomarker for ALS and FTLDEmily Feneberg, Elizabeth Gray, Olaf Ansorge, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2025
Progression and life expectancy in primary lateral sclerosisDavid G Lester, Alexander G Thompson, Kevin Talbot, et al.
Pageof 26

Showing results (51-60 of 255) with videos related to

Sort By:
Pageof 26
Human Molecular Genetics|December 17, 2009
Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model miceBradley J Turner, Steven Ackerley, Kay E Davies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 12, 2015
Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosisMartin R Turner, Raph Goldacre, Kevin Talbot, et al.
Annals of Neurology|October 21, 2016
Psychiatric disorders prior to amyotrophic lateral sclerosisMartin R Turner, Raph Goldacre, Kevin Talbot, et al.
Brain Communications|August 14, 2023
Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosisAlexander G Thompson, Rachael Marsden, Kevin Talbot, et al.
Journal of Medical Ethics|July 11, 2013
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseasesLes Halpin, Julian Savulescu, Kevin Talbot, et al.
Brain : a Journal of Neurology|November 15, 2011
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosisGwenaëlle Douaud, Nicola Filippini, Steven Knight, et al.
Neuromuscular Disorders : NMD|September 18, 2012
Spinal muscular atrophy at the crossroads of basic science and therapyJames N Sleigh, Stuart J Grice, Kay E Davies, et al.
Neurobiology of Disease|April 1, 2009
Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse modelBradley J Turner, Nicholas J Parkinson, Kay E Davies, et al.
Molecular Neurobiology|February 21, 2018
Towards a TDP-43-Based Biomarker for ALS and FTLDEmily Feneberg, Elizabeth Gray, Olaf Ansorge, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2025
Progression and life expectancy in primary lateral sclerosisDavid G Lester, Alexander G Thompson, Kevin Talbot, et al.
Pageof 26